Infection Control Market Expected to Reach $38.61 Billion by 2028

According to a new report published by Allied Market Research, titled, “Infection Control Market by Product & Service, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2028," the global infection control market was valued at $32,613.75 million in 2020, and is projected to reach $38,616.77 million by 2028, registering a CAGR of 3.0% from 2021 to 2028.

Many microorganisms such as fungi, virus, and bacteria are the pathogenic agents for infections. Infections are majorly transmitted through hands, inhalation, ingestion, and equipment. Different types of infections affecting body including hospital acquired infections (HAIs), common childhood infections, stomach & intestinal infections, skin infections, lung & respiratory infections, eye infections, ear infections, and sexually transmitted infections (STDs). The hands of patients can carry microbes to other body sites, equipment, and healthcare staff. Therefore, infection control is concerned with preventing and controlling health care associated infections and sterilization technique is a major component of invasive surgical procedure.

Increase in number of surgical procedures, rise in incidence of hospital acquired infection, technological advancements in sterilization and disinfection technologies, surge in geriatric population, increase in government and non-government initiatives relating to spreading awareness concerning need for disinfection and need of proper hygiene are the major factors that boost the growth of the market. In addition, reintroduction of ethylene oxide sterilization, incidence of chronic diseases, rise in outsourcing of sterilization services among hospitals, pharmaceutical & medical device companies, surge in use of E-beam sterilization, and increase in adoption of single use medical nonwovens and devices are other factors that further drive the growth of the market. However, adverse effects of chemical disinfectants and concerns regarding the safety of reprocessed instruments are expected to restrain the growth of the infection control market. Conversely, rise in adoption of single use medical nonwovens and devices is expected to offer lucrative opportunities during the forecast period.

Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. Increase in use of infection control products such as gloves, face masks, gowns, shoe cover, sterilization products, disinfection products, and others in hospitals & clinics is anticipated show positive impact on the market. Moreover, to protect healthcare workers, ordinary people are also pursuing masks to comply with government mask-wearing directives and recommendations, which further drives the demand for face masks. Thus, overall positive impact of COVID-19 on infection control market was observed.

The infection control market is segmented into product & service, end user, and region. 

On the basis of product & service, the market is categorized into sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. Presently, the protective barriers segment dominated the global infection control market in 2020, and is anticipated to continue this trend during the forecast period. The key factors such as rise in adoption of medical nonwovens, such as face masks, surgical drapes, and gowns, due to the surge in COVID-19 cases, surge in number of surgeries, and increase in public awareness towards personal hygiene.

According to end user, the infection control market is classified into hospitals & clinics, pharmaceutical & medical device companies, and others. The hospitals & clinics segment is anticipated to depict significant growth during the forecast period due to rise in prevalence of hospital-acquired infections (HAIs), surge in geriatric population (as this population is more prone to various chronic diseases), rise in volume of surgical procedures performed in hospitals, and surge in number of hospitals and clinics worldwide boost the market growth.

Key Findings Of The Study 

• By product & service, the protective barriers segment held largest infection control market share in 2020, and is expected to remain dominant throughout the forecast period.
• By end user, the hospitals & clinics segment held largest infection control market share in 2020 and is expected to remain dominant throughout the forecast period. 
• By region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 4.3% during the forecast period. 

In 2020, North America accounted for the major share in the infection control market, owing to rise in adoption of sterilization and disinfection products along with contract sterilization services, increase in need for infection control to minimize the prevalence of HAIs, and surge in the geriatric population act as the key drivers of the market in this region. However, Asia-Pacific is projected to register the fastest growth during the forecast period, owing to increase in awareness related to personal hygiene, rise in number of surgical procedures, availability of trained medical professionals, and supportive reimbursement policies in the healthcare system.